Atrial Fibrillation

 
Smart Ring Outperforms Apple Watch for Atrial Fibrillation Detection
April 21, 2025

The CART ring was superior to the Apple Watch in automated AF detection with fewer unclassified ECGs, but neither device should serve as a definitive diagnostic tool.

Diagnosis of Atrial Fibrillation: A Guideline Topline
April 10, 2025

This AF guideline topline offers an at-a-glance look at the most recent ACC/AHA guidance on diagnosis of the arrhythmia.

First Rivaroxaban Generics (2.5 mg) Get FDA Approval
March 05, 2025

The first low-dose rivaroxaban generic tablets to be FDA approved lead a field crowded with applications for formulations of all the higher doses.

Atrial Fibrillation More Prevalent in US Than Previously Estimated: Daily Dose
September 26, 2024

Your daily dose of the clinical news you may have missed.

Individuals with Atrial Fibrillation Who Use Wearable Devices Report Heightened Symptom Monitoring, Treatment Concerns
July 22, 2024

Participants with AF who used wearable devices reported higher anxiety levels and increased health care usage than nonusers, according to a new study.

Atrial Fibrillation May be More Common in Younger Adults than Previously Thought: Daily Dose
May 02, 2024

Your daily dose of the clinical news you may have missed.

New Data Suggest Atrial Fibrillation May be More Common in Younger Adults than Previously Thought
April 23, 2024

Patients with AF aged younger than 65 years have substantial comorbidity burden that may impact their future risk of mortality, reported researchers.

Concomitant SSRI and DOAC Use Increases Risk of Major Bleeding, Including ICH: New Findings
March 25, 2024

Overall, a 33% increased risk of major bleeding was seen, with risk highest during the first 30 days of concomitant use and persistent, but lower, after 6 months.

Apixaban and Aspirin Equal in Preventing Stroke Recurrence in Cardiopathy: Daily Dose
February 19, 2024

Your daily dose of the clinical news you may have missed.

Apixaban and Aspirin Appear Equal Against Recurrent Stroke in Individuals with Cardiopathy
February 12, 2024

Anticoagulation and antiplatelet therapy appeared equally effective in reducing risk of recurrent stroke following cryptogenic stroke in persons with evidence of atrial cardiopathy.